Holen Sie sich die Stockscreener-App
0.765
5.39%
-0.0436
Schlusskurs vom Vortag:
$0.8086
Offen:
$0.82
24-Stunden-Volumen:
21,033
Relative Volume:
0.12
Marktkapitalisierung:
$5.58M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-1.92M
KGV:
-1.953
EPS:
-0.3917
Netto-Cashflow:
$-5.26M
1W Leistung:
-11.01%
1M Leistung:
-25.73%
6M Leistung:
-52.19%
1J Leistung:
-46.13%
1-Tages-Spanne:
$0.76
$0.82
1-Wochen-Bereich:
$0.76
$0.8969
52-Wochen-Spanne:
$0.5306
$7.00
Mustang Bio Inc Stock (MBIO) Company Profile
Firmenname
Mustang Bio Inc
Sektor
Branche
Telefon
(781) 652-4500
Adresse
95 SAWYER RD, WALTHAM, NY
Compare MBIO vs VRTX, REGN, ALNY, ARGX, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MBIO
Mustang Bio Inc
|
0.765 | 5.90M | 0 | -1.92M | -5.26M | -0.3917 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-18 | Eingeleitet | BTIG Research | Buy |
| 2020-10-02 | Eingeleitet | B. Riley FBR | Buy |
| 2019-11-20 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-06-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-12-21 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Mustang Bio Inc Aktie (MBIO) Neueste Nachrichten
If You Invested $1,000 in Mustang Bio (MBIO) - Stock Titan
Mustang Bio Inc stock faces prolonged decline amid biotech sector volatility and pipeline uncertaint - AD HOC NEWS
Growth Recap: Whats the profit margin of Mustang Bio Inc2026 Final Week & AI Enhanced Execution Alerts - baoquankhu1.vn
Mustang Bio, Inc. 2025 Annual Report: Clinical-Stage Biopharmaceutical Pipeline, Risks, and Regulatory Overview - Minichart
Mustang Bio 10-K: Net loss narrows to $(1.9)M; cash $17.3M, runway ≥12 months - TradingView
MBIO: 2025 net loss narrowed to $1.9M, cash rose to $17.3M, and liquidity outlook improved after restructuring - TradingView
Mustang Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Mustang Bio (NASDAQ: MBIO) details GBM pipeline, Orphan status and cash - Stock Titan
Mustang Bio Inc Stock (ISIN: US62815P1003) Faces Analyst Sell Rating Amid Biotech Volatility - AD HOC NEWS
Mustang Bio Shares Surge After FDA Grants Orphan Drug Status - MSN
MBIO Soars on Orphan Drug Nod for Investigational Brain Cancer Therapy - MSN
Is Mustang Bio Inc. stock a safe buy before earnings2026 Institutional & Verified Technical Trade Signals - Naître et grandir
Buy Signal: Is Cheetah Mobile Inc. Depositary Receipt forming a double bottom2025 Geopolitical Influence & Comprehensive Market Scan Reports - baoquankhu1.vn
Is NKSH stock vulnerable to regulatory risksPortfolio Performance Report & Safe Entry Trade Reports - Naître et grandir
Sell Signal: Whats the profit margin of Mustang Bio IncDividend Hike & AI Based Trade Execution Alerts - baoquankhu1.vn
MBIO PE Ratio & Valuation, Is MBIO Overvalued - Intellectia AI
Short Interest in Mustang Bio, Inc. (NASDAQ:MBIO) Rises By 405.2% - Defense World
MBIO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
MBIO Should I Buy - Intellectia AI
Critical Contrast: Mustang Bio (NASDAQ:MBIO) & AstraZeneca (NASDAQ:AZN) - Defense World
Market Overview: Is LAND still a buy after recent gainsWeekly Trading Summary & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
MBIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
MSN Money - MSN
Will CWAN stock boost dividends further2025 Trade Ideas & AI Powered Buy/Sell Recommendations - mfd.ru
Is ARQQ benefiting from interest rate changesStop Loss & Free Daily Entry Point Trade Alerts - mfd.ru
Glioblastoma Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | InovioPharma, Pfizer, Roche, ACADIA Pharma, BioNTech, Oncotelic Therapeutics - Barchart.com
T-cell Therapy Market is Expected to Grow USD 15.3 Billion by 2033 | At CAGR 15.11% - vocal.media
US Market Wrap: Will Akoya Biosciences Inc benefit from green energy policiesTreasury Yields & Consistent Growth Stock Picks - baoquankhu1.vn
Glioma Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com
Aug Setups: Will SHRFP benefit from government policyMarket Growth Review & Growth Oriented Trading Recommendations - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
How cyclical is Mustang Bio Inc.’s revenue streamMarket Volume Summary & Daily Risk Controlled Trade Plans - mfd.ru
Aug Rallies: Does Mustang Bio Inc have a sustainable dividendEntry Point & Reliable Price Breakout Alerts - baoquankhu1.vn
MACD Signal: What is OneMain Holdings Incs debt to equity ratioWeekly Profit Summary & Momentum Based Trading Ideas - baoquankhu1.vn
Mustang Bio sells assets and ends lease with AbbVie - MSN
Can Mustang Bio Inc. sustain its profitability2025 Sector Review & Daily Chart Pattern Signals - mfd.ru
Cellares and City of Hope to Automate Manufacturing of Solid Tumor CAR T Cell Therapy - The Medicine Maker
CEO Moves: Can Mustang Bio Inc sustain its profitabilityJuly 2025 PostEarnings & Accurate Intraday Trade Tips - baoquankhu1.vn
Aug Technicals: Does Mustang Bio Inc have pricing power2025 Macro Impact & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Returns Recap: How is ARRY managing supply chain issues2025 Historical Comparison & Safe Entry Momentum Tips - baoquankhu1.vn
Why millennials buy Thor Industries Inc. stockQuarterly Investment Review & Consistent Return Strategy Ideas - bollywoodhelpline.com
History Review: Can Tiziana Life Sciences Ltd sustain earnings growthEarnings Risk Summary & High Accuracy Trade Alerts - baoquankhu1.vn
CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant
Aug Highlights: What is GDS Holdings Limited Depositary Receipts revenue forecastJuly 2025 Earnings & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Momentum Screeners Rank Haria Exports Limited in Top 5 TodayEconomic Impact on Stocks & Minimal Investment Trading - Bollywood Helpline
Published on: 2026-01-11 00:49:59 - Bộ Nội Vụ
Why analysts remain bullish on Mustang Bio Inc. stock2025 Volatility Report & High Accuracy Swing Trade Signals - Улправда
How strong dollar benefits Zinc One Resources Inc. (RH3) stock2025 Performance Recap & Stepwise Trade Signal Implementation - Улправда
Will Mustang Bio Inc. stock gain from strong economy2025 Volume Leaders & AI Optimized Trade Strategies - Улправда
2026 world cup match report pre match breakdownBuy Signal & Weekly High Potential Stock Alerts - Улправда
How StealthGas Inc. stock responds to policy changesDay Trade & Risk Controlled Stock Pick Alerts - Улправда
Finanzdaten der Mustang Bio Inc-Aktie (MBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):